Biogen, Inc. (BIIB):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:Biogen, Inc. (BIIB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME1307D
◆発行会社(調査会社):GlobalData
◆発行日:2016年2月24日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Summary

Biogen, Inc. (Biogen) is a global biotechnology company that discovers, develops, manufactures and commercializes therapies for treating neurodegenerative diseases, hematologic conditions and autoimmune disorders. The company’s marketed product portfolio includes Avonex, Tysabri, Tecfidera, Fampyra, and Plegridy for the treatment of multiple sclerosis (MS); Eloctate for hemophilia A; Alprolix for hemophilia B and Fumaderm (fumaric acid esters) for plaque psoriasis. Through its joint venture company, Samsung Bioepis the company also develops, manufactures and markets biosimilars. The company also has several products in its developmental pipeline targeting various indications namely MS, hemophilia and other neurodegenerative diseases. The company markets its products in the US, several European countries and Japan through its own sales forces and marketing groups. Biogen is headquartered in Cambridge, Massachusetts, the US.

Biogen, Inc. (BIIB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Biogen, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Biogen, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Biogen, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Biogen, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8
Biogen, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Biogen, Inc., Medical Equipment, Deal Details 10
Partnerships 10
Oklahoma Medical Research Foundation Enters into Research Agreement with Biogen 10
Regulus Therapeutics Enters into Agreement with Biogen Idec for microRNA Biomarkers 11
Regulus Therapeutics Amends Agreement With Biogen Idec 12
Regulus Therapeutics Enters Into An Agreement With Biogen Idec For Biomarkers 13
Orasi Medical Enters Into An Agreement With Biogen Idec 14
Debt Offering 15
Biogen Raises USD1.5 Billion in Public Offering of 2.9% Notes Due 2020 15
Biogen Raises USD1.75 Billion in Public Offering of 5.2% Notes Due 2045 17
Biogen Raises USD1.75 Billion in Public Offering of 4.05% Notes Due 2025 19
Biogen Raises USD1 Billion in Public Offering of 3.625% Notes Due 2022 21
Acquisition 23
Bristol-Myers Rumored To Acquire Biogen Idec 23
Biogen, Inc. – Key Competitors 24
Key Employees 25
Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Biogen, Inc., Medical Equipment, Key Facts, 2015 1
Biogen, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Biogen, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Biogen, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Biogen, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Biogen, Inc., Deals By Market, 2010 to YTD 2016 8
Biogen, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Oklahoma Medical Research Foundation Enters into Research Agreement with Biogen 10
Regulus Therapeutics Enters into Agreement with Biogen Idec for microRNA Biomarkers 11
Regulus Therapeutics Amends Agreement With Biogen Idec 12
Regulus Therapeutics Enters Into An Agreement With Biogen Idec For Biomarkers 13
Orasi Medical Enters Into An Agreement With Biogen Idec 14
Biogen Raises USD1.5 Billion in Public Offering of 2.9% Notes Due 2020 15
Biogen Raises USD1.75 Billion in Public Offering of 5.2% Notes Due 2045 17
Biogen Raises USD1.75 Billion in Public Offering of 4.05% Notes Due 2025 19
Biogen Raises USD1 Billion in Public Offering of 3.625% Notes Due 2022 21
Bristol-Myers Rumored To Acquire Biogen Idec 23
Biogen, Inc., Key Competitors 24
Biogen, Inc., Key Employees 25
Biogen, Inc., Other Locations 27
Biogen, Inc., Subsidiaries 27

List of Figures
Biogen, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Biogen, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Biogen, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Biogen, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Biogen, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Biogen, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6
Biogen, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Biogen, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8

【掲載企業】

Genmab Ltd.
Novartis AG
Genzyme Corporation
Pfizer Inc.
Sanofi
AbbVie Inc.
Bayer HealthCare Pharmaceuticals
Johnson & Johnson
Merck & Co., Inc.
Teva Pharmaceutical Industries Limited
Opexa Therapeutics, Inc.
BG Medicine, Inc.
Synthetic Biologics, Inc.
Receptos, Inc.
Forward Pharma A/S
Pfenex Inc.
Active Biotech AB
MediciNova, Inc.

★調査レポート[Biogen, Inc. (BIIB):企業のM&A・提携動向(医療機器分野)] (コード:GDME1307D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Biogen, Inc. (BIIB):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆